Conference Coverage
ReachMD brings you the latest research, announcements, and conversations from the most important medical conferences around the world. Join us on the conference floor with keynote speakers, experts, and opinion leaders.
196-210 of 582
Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Project Oncology®Biomarker Breakthroughs: A Look at What’s Next for Kidney Cancer Care
Ryan Quigley
David F. McDermott, MD
Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Project Oncology®Optimizing Nivolumab in NSCLC: Implications for Cost, Access, and Outcomes
Aline Fares, MD
Exploring Timing in MS Therapy: Real-World Outcomes of Fumarates
NeuroFrontiersExploring Timing in MS Therapy: Real-World Outcomes of Fumarates
Managing MS in Older Adults: Top 5 Clinical Considerations
NeuroFrontiersManaging MS in Older Adults: Top 5 Clinical Considerations
Yinan Zhang, MD
One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Project Oncology®One Year or Two? DANTE Trial Explores Immunotherapy Duration in Metastatic Melanoma
Investigating the Impact of Exercise on Cancer Immunotherapy Outcomes
Project Oncology®Investigating the Impact of Exercise on Cancer Immunotherapy Outcomes
Samhitha Gundakaram, MBBS
- advertisement
What's New in Dermatology: Key Updates on Emerging Therapies
DermConsultWhat's New in Dermatology: Key Updates on Emerging Therapies
James Del Rosso, DO, FAOCD
Charles Turck, PharmD, BCPS, BCCCP
Innovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
NeuroFrontiersInnovations in Bladder Monitoring for MS: Advancing Remote Evaluation Tools
Riley Bove, MD, MMSc
Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Project Oncology®Overall Survival with Neoadjuvant Therapy in HNSCC: Examining Real-World Data
Vanessa Helou, MD
Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
Project Oncology®Predicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
George Laliotis, MD, MPH, MHA
Managing MS in Women: How to Guide Patients Through Pregnancy and Menopause
NeuroFrontiersManaging MS in Women: How to Guide Patients Through Pregnancy and Menopause
Riley Bove, MD, MMSc
Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
Project Oncology®Stratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
- advertisement
Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
Project Oncology®Immune Checkpoint Inhibitors Show Promise in Patients with Oncogene Driver-Negative NSCLC Who Have Never Smoked
TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Project Oncology®TILplus Score as a Potential Predictive Biomarker in First-Line ICI Therapy for mccRCC
Digital CBT and Pulmonary Fibrosis: Addressing Anxiety and Quality of Life
Clinician's RoundtableDigital CBT and Pulmonary Fibrosis: Addressing Anxiety and Quality of Life
Jessica Shull, PhD
Joshua Solomon, MD
Ryan Quigley
